Immatics (IMTX) EBITDA Margin (2019 - 2025)
Immatics (IMTX) reported EBITDA Margin of 181.09% for Q4 2025, down 26076.0% on a YoY basis from N/an in Q4 2024, and up 81.57% sequentially from 982.48% in Q3 2025.
Immatics (IMTX) EBITDA Margin (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of EBITDA Margin data on file, last reported at 181.09% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin fell 26076.0% year-over-year to 181.09%; the trailing twelve-month figure through Dec 2025 stood at 490.55% (down 49607.0% YoY), and the FY2025 full-year result was 377.11%, down 35233.0% from the prior year.
- EBITDA Margin advanced to 181.09% in Q4 2025, from 982.48% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 82.16% in Q1 2022 to a low of 1987.02% in Q2 2025.
- A 5-year average of 302.18% and a median of 159.61% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin surged 174351 bps in 2021 and slumped 189021 bps in 2025, its largest moves.
- Tracing IMTX's EBITDA Margin over 5 years: stood at 108.81% in 2021, then surged by 78 bps to 23.52% in 2022, then plunged by 676 bps to 182.41% in 2023, then soared by 144 bps to 79.66% in 2024, then slumped by 327 bps to 181.09% in 2025.
- Business Quant data shows IMTX's EBITDA Margin at 181.09% in Q4 2025, 982.48% in Q3 2025, and 1987.02% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -181.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -181.09% |
| Sep 30, 2025 | -982.48% |
| Jun 30, 2025 | -1,987.02% |
| Mar 31, 2025 | -291.60% |
| Dec 31, 2024 | 79.66% |
| Sep 30, 2024 | -29.55% |
| Jun 30, 2024 | -96.81% |
| Mar 31, 2024 | -7.93% |
| Dec 31, 2023 | -182.41% |
| Sep 30, 2023 | -473.57% |
| Jun 30, 2023 | -115.21% |
| Mar 31, 2023 | -237.40% |
| Dec 31, 2022 | -23.52% |
| Sep 30, 2022 | -138.13% |
| Jun 30, 2022 | -76.92% |
| Mar 31, 2022 | 82.16% |
| Dec 31, 2021 | -108.81% |
| Sep 30, 2021 | -424.86% |
| Jun 30, 2021 | -523.47% |
| Mar 31, 2021 | -324.69% |